Electromagnetic Navigation Bronchoscopy Shows Positive Response In Lung Cancer Study

An analysis of 12-month results from NAVIGATE, the largest, prospective, multicenter trial designed to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using Medtronic's...

Scientists Discover Possible way to Make Resistant Melanomas Susceptible to Immunotherapy

Researchers at the Ludwig Cancer Research Institute,  an international community of scientists focused on cancer research, with headquarters in New York City, NY and...

Minimally Invasive Endoscopy Tool may Change Treatment for Pancreatic Cancer Patients

A minimally invasive treatment option may change treatment options for patients with pancreatic cancer. The development of significantly more effective treatment options is possible...

Dr. Brawley Goes to Baltimore…and Washington

The latest chapter in Otis W. Brawley, MD’s illustrious career in cancer prevention and control commenced earlier this month when he began his tenure...

Study Shows How Molecular Profiling may Help Catch Lung Cancer Early,...

The world's first genetic sequencing of precancerous lung lesions, referred to as lung carcinoma in situ (CIS) are the preinvasive precursor to squamous cell...

FDA Approves Samsung Bioepis’ First Oncology Biosimilar Trastuzumab-dttb

The U.S. Food and Drug Administration (FDA) has approved trastuzumab-dttb (Ontruzant®; Samsung Bioepis) a biosimilar referencing* trastuzumab (Herceptin®; Genentech/Roche), for adjuvant treatment of HER2-overexpressing...

Financial Toxicity: Privately Insured Cancer Survivors Carry Greater Medical Debt

Younger cancer survivors have are facing significant hardship as a result of their cancer treatment. A recent study also shows that cancer survivors in...

Trifluridine/tipiracil Significantly Improved Overall Survival versus Placebo in Gastric Cancer

The safety and efficacy of trifluridine/tipiracil (Lonsurf®; Taiho Oncology/Taiho Pharmaceutical and Servier) in patients who had undergone gastrectomy, the surgical removal of a part...

FDA Accepts sBLA for Atezolizumab + Abraxane and Carboplatin for Metastatic...

The United States Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for atezolizumab (Tecentriq®; Roche/Genentech) in combination with albumin-bound...

Neoleukin-2/15 – A Novel Immunotherapy Agent Designed to Avoid Common...

Scientists at the University of Washington Medicine's Institute for Protein Design (IPD) in Seattle, Washington, have created a new protein that mimics the action...

Latest